Table 3.
A comparison of treatment outcomes between female and male tuberculosis patients stratified by their demographic and clinical characteristics, Ebonyi state, Nigeria, 2011–2012
| Variables | Female | Male | P value | |||
|---|---|---|---|---|---|---|
| Successful, n (%) | Unsuccessful, n (%) | Successful, n (%) | Unsuccessful, n (%) | |||
| Age (years) | ||||||
| ⩽40 | 395 (79·6) | 101 (20·4) | 435 (76·4) | 134 (23·6) | 0·21 | |
| >40 | 156 (74·6) | 53 (25·4) | 282 (71·6) | 112 (28·4) | 0·42 | |
| Residence | ||||||
| Rural | 379 (76·7) | 115 (23·3) | 514 (74·9) | 172 (25·1) | 0·64 | |
| Urban | 172 (81·5) | 39 (18·5) | 203 (73·3) | 74 (26·7) | 0·03 | |
| Facility | ||||||
| Private | 472 (83·0) | 97 (17·0) | 639 (77·8) | 182 (22·2) | 0·02 | |
| Public | 79 (8·1) | 57 (41·9) | 78 (54·9) | 64 (45·1) | 0·6 | |
| Treatment category | ||||||
| New | 515 (78·1) | 144 (21·9) | 668 (74·8) | 225 (25·2) | 0·13 | |
| Re-treatment | 36 (78·3) | 10 (21·7) | 49 (70·0) | 21 (30·0) | 0·32 | |
| Type of TB | ||||||
| Extrapulmonary | 25 (52·1) | 23 (47·9) | 18 (39·1) | 28 (60·9) | 0·21 | |
| Pulmonary | 526 (80·1) | 131 (19·9) | 699 (76·2) | 218 (23·8) | 0·07 | |
| HIV status | ||||||
| Negative | 446 (82·4) | 95 (17·6) | 597 (76·1) | 188 (23·9) | 0·005 | |
| Positive | 105 (64·0) | 59 (36·0) | 120 (67·4) | 58 (32·6) | 0·5 | |
| Treatment regimen | ||||||
| 8 months | 281 (75·5) | 91 (24·5) | 374 (73·8) | 133 (26·2) | 0·6 | |
| 6 months | 270 (81·1) | 63 (18·9) | 343 (75·2) | 113 (24·8) | 0·05 | |
HIV, Human immunodeficiency virus.